Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Invested Capital (2016 - 2025)

Historic Invested Capital for Marimed (MRMD) over the last 15 years, with Q3 2025 value amounting to $58.7 million.

  • Marimed's Invested Capital fell 1848.09% to $58.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.7 million, marking a year-over-year decrease of 1848.09%. This contributed to the annual value of $62.5 million for FY2024, which is 1470.44% down from last year.
  • Marimed's Invested Capital amounted to $58.7 million in Q3 2025, which was down 1848.09% from $62.1 million recorded in Q2 2025.
  • In the past 5 years, Marimed's Invested Capital registered a high of $113.0 million during Q2 2023, and its lowest value of $14.8 million during Q1 2021.
  • Its 5-year average for Invested Capital is $62.8 million, with a median of $62.5 million in 2024.
  • Per our database at Business Quant, Marimed's Invested Capital soared by 2013952.73% in 2021 and then crashed by 3556.38% in 2024.
  • Over the past 5 years, Marimed's Invested Capital (Quarter) stood at $36.3 million in 2021, then soared by 114.12% to $77.8 million in 2022, then decreased by 5.87% to $73.3 million in 2023, then fell by 14.7% to $62.5 million in 2024, then fell by 6.04% to $58.7 million in 2025.
  • Its Invested Capital stands at $58.7 million for Q3 2025, versus $62.1 million for Q2 2025 and $63.1 million for Q1 2025.